CLARITY News and Research

RSS
The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.
GE Healthcare introduces Veo CT image reconstruction technology in Canada

GE Healthcare introduces Veo CT image reconstruction technology in Canada

Komen for the Cure applauds new mammography guidelines

Komen for the Cure applauds new mammography guidelines

Capitol Hill prepares for politically charged votes on debt limit

Capitol Hill prepares for politically charged votes on debt limit

Congress should avoid cutting international affairs budget, Clinton says

Congress should avoid cutting international affairs budget, Clinton says

Obama administration rolls out rule for health exchanges

Obama administration rolls out rule for health exchanges

BioLineRx initiates enrollment in BL-1020 Phase II/III trial against schizophrenia

BioLineRx initiates enrollment in BL-1020 Phase II/III trial against schizophrenia

Saint-Gobain introduces new C-Flex ULTRA TPE pump tubing for biopharmaceutical applications

Saint-Gobain introduces new C-Flex ULTRA TPE pump tubing for biopharmaceutical applications

FDA issues final rulemaking on testing and labeling of sunscreen products

FDA issues final rulemaking on testing and labeling of sunscreen products

ACS honors Los Angeles general surgeon with 2011 Jacobson Innovation Award

ACS honors Los Angeles general surgeon with 2011 Jacobson Innovation Award

FDA draft guidance outlines roadmap for discussion on nanotechnology in regulated products

FDA draft guidance outlines roadmap for discussion on nanotechnology in regulated products

Adaptive optics technology reveals eye's cellular structure with unprecedented detail

Adaptive optics technology reveals eye's cellular structure with unprecedented detail

GTx to initiate two Ostarine Phase III trial for treatment of muscle wasting in patients with NSCLC

GTx to initiate two Ostarine Phase III trial for treatment of muscle wasting in patients with NSCLC

Orexigen meets FDA to gain clarity on approval for Contrave NDA to treat obesity

Orexigen meets FDA to gain clarity on approval for Contrave NDA to treat obesity

New imaging method using fluorescent nanotubes can peer clearly into living mouse's innards

New imaging method using fluorescent nanotubes can peer clearly into living mouse's innards

Quality Systems fiscal 2011 fourth quarter net revenues increase 24% to $97.1 million

Quality Systems fiscal 2011 fourth quarter net revenues increase 24% to $97.1 million

16 Countries announce new commitments to reduce maternal, newborn and child mortality

16 Countries announce new commitments to reduce maternal, newborn and child mortality

Tips to get better sleep

Tips to get better sleep

State roundup: Gov. Brown offers revisions to health budget

State roundup: Gov. Brown offers revisions to health budget

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

In effort to find common ground on budget talks, GOP Medicare message becomes mixed

In effort to find common ground on budget talks, GOP Medicare message becomes mixed

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.